Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report
出版年份 2020 全文链接
标题
Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report
作者
关键词
-
出版物
Parkinsons Disease
Volume 2020, Issue -, Pages 1-7
出版商
Hindawi Limited
发表日期
2020-02-20
DOI
10.1155/2020/2671070
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dietary lysophosphatidylcholine-EPA enriches both EPA and DHA in the brain: Potential treatment for depression
- (2018) Poorna ChandraRao Yalagala et al. JOURNAL OF LIPID RESEARCH
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- Oral Administration of Ethanolamine Glycerophospholipid Containing a High Level of Plasmalogen Improves Memory Impairment in Amyloid β-Infused Rats
- (2017) Shinji Yamashita et al. LIPIDS
- Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
- (2017) Paula Perez-Pardo et al. Frontiers in Aging Neuroscience
- Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
- (2017) Takehiko Fujino et al. EBioMedicine
- Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme
- (2016) Marcus O.W. Grimm et al. Biochemistry and Cell Biology
- Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases
- (2016) Amanda Lo Van et al. BIOCHIMIE
- Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice
- (2016) Kathryn E. Hopperton et al. Journal of Neuroinflammation
- Measurement of Ether Phospholipids in Human Plasma with HPLC–ELSD and LC/ESI–MS After Hydrolysis of Plasma with Phospholipase A1
- (2016) Shiro Mawatari et al. LIPIDS
- α-Synuclein dimerization in erythrocytes of Gaucher disease patients: correlation with lipid abnormalities and oxidative stress
- (2016) Marina Moraitou et al. NEUROSCIENCE LETTERS
- Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
- (2016) Edith Miville-Godbout et al. PLoS One
- Neuronal Orphan G-Protein Coupled Receptor Proteins Mediate Plasmalogens-Induced Activation of ERK and Akt Signaling
- (2016) Md. Shamim Hossain et al. PLoS One
- Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys
- (2015) Laurent Grégoire et al. BEHAVIOURAL BRAIN RESEARCH
- Plasmalogen phospholipids protect internodal myelin from oxidative damage
- (2015) Adrienne M. Luoma et al. FREE RADICAL BIOLOGY AND MEDICINE
- Biomarkers of Parkinson’s disease: Present and future
- (2015) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain
- (2015) M. Lagarde et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
- (2015) Qinqin Wang et al. Translational Neurodegeneration
- Lipid Rafts, Endoplasmic Reticulum and Mitochondria in the Antitumor Action of the Alkylphospholipid Analog Edelfosine
- (2014) Consuelo Gajate et al. Anti-Cancer Agents in Medicinal Chemistry
- Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
- (2013) Sarah K. Abbott et al. MOVEMENT DISORDERS
- Anticancer mechanisms and clinical application of alkylphospholipids
- (2012) Wim J. van Blitterswijk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Functions of plasmalogen lipids in health and disease
- (2012) Nancy E. Braverman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Plasmalogens the neglected regulatory and scavenging lipid species
- (2011) Stefan Wallner et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Oxidative Stress in Parkinson's Disease
- (2010) Chun Zhou et al. Annals of the New York Academy of Sciences
- Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
- (2009) Charalampos Dragonas et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Plasmalogens in Biological Systems: Their Role in Oxidative Processes in Biological Membranes, their Contribution to Pathological Processes and Aging and Plasmalogen Analysis
- (2009) J. Leßig et al. CURRENT MEDICINAL CHEMISTRY
- Occurrence Risk and Structure of Depression in Parkinson Disease With and Without Dementia: Results From the GEPAD Study
- (2009) Oliver Riedel et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- The epidemiology of dementia associated with Parkinson disease
- (2009) Dag Aarsland et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- Cognitive impairment in 873 patients with idiopathic Parkinson's disease
- (2008) O. Riedel et al. JOURNAL OF NEUROLOGY
- REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: A two-year follow up
- (2008) Elena Sinforiani et al. MOVEMENT DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started